BrightSpring Health Services (NASDAQ:BTSG) Given New $30.00 Price Target at UBS Group

BrightSpring Health Services (NASDAQ:BTSG) had its price objective raised by UBS Group from $22.00 to $30.00 in a research note published on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other brokerages have also recently commented on BTSG. Wells Fargo & Company boosted their target price on BrightSpring Health Services from $17.00 to $21.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. CJS Securities started coverage on BrightSpring Health Services in a report on Thursday, December 12th. They issued an “outperform” rating and a $27.00 price objective for the company. Mizuho lifted their target price on BrightSpring Health Services from $17.00 to $20.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Morgan Stanley upped their price target on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Tuesday, December 17th. Finally, BTIG Research lifted their price objective on shares of BrightSpring Health Services from $15.00 to $20.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $19.42.

BrightSpring Health Services Trading Up 4.5 %

Shares of BTSG stock opened at $23.75 on Wednesday. BrightSpring Health Services has a 1 year low of $7.85 and a 1 year high of $23.83. The firm has a market capitalization of $4.14 billion and a PE ratio of -91.35. The stock has a fifty day moving average of $18.61 and a two-hundred day moving average of $15.82. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35.

BrightSpring Health Services (NASDAQ:BTSG) last announced its earnings results on Friday, November 1st. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The company had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.72 billion. The company’s revenue was up 28.8% on a year-over-year basis. As a group, research analysts expect that BrightSpring Health Services will post 0.59 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. L & S Advisors Inc purchased a new position in BrightSpring Health Services during the 3rd quarter valued at about $1,247,000. Virtu Financial LLC purchased a new position in BrightSpring Health Services during the third quarter valued at approximately $522,000. Assenagon Asset Management S.A. acquired a new position in BrightSpring Health Services in the 3rd quarter valued at approximately $1,822,000. LMR Partners LLP purchased a new stake in BrightSpring Health Services in the 3rd quarter worth approximately $493,000. Finally, JPMorgan Chase & Co. boosted its stake in shares of BrightSpring Health Services by 275.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 163,618 shares of the company’s stock valued at $2,402,000 after buying an additional 120,005 shares during the period.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.